BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17879274)

  • 21. Interleukin 27 is up-regulated in patients with active inflammatory bowel disease.
    Furuzawa Carballeda J; Fonseca Camarillo G; Yamamoto-Furusho JK
    Immunol Res; 2016 Aug; 64(4):901-7. PubMed ID: 27221243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-18 is increased only in a minority of patients with active Crohn's disease.
    Schmidt C; Giese T; Goebel R; Schilling M; Marth T; Ruether A; Schreiber S; Zeuzem S; Meuer SC; Stallmach A
    Int J Colorectal Dis; 2007 Sep; 22(9):1013-20. PubMed ID: 17318554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Colonic expression of gamma-interferon and interleukin-10 in Crohn's disease and ulcerative colitis].
    Kallel L; Boubaker J; Louzir H; Ben Ahmed M; Sassi A; Boubaker S; Zouari B; Filali A
    Presse Med; 2005 Jan; 34(1):8-12. PubMed ID: 15685091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease.
    Hyams JS; Fitzgerald JE; Wyzga N; Muller R; Treem WR; Justinich CJ; Kreutzer DL
    J Pediatr Gastroenterol Nutr; 1995 Nov; 21(4):419-25. PubMed ID: 8583293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.
    Troncone R; Caputo N; Campanozzi A; Cucciardi M; Esposito V; Russo R; De Vizia B; Greco L; Cucchiara S
    Gut; 1997 Jul; 41(1):60-5. PubMed ID: 9274473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactive IL-18 expression is up-regulated in Crohn's disease.
    Monteleone G; Trapasso F; Parrello T; Biancone L; Stella A; Iuliano R; Luzza F; Fusco A; Pallone F
    J Immunol; 1999 Jul; 163(1):143-7. PubMed ID: 10384110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations of plasma citrulline levels with clinical and endoscopic score and blood markers according to small bowel involvement in pediatric Crohn disease.
    Lee EH; Ko JS; Seo JK
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):570-5. PubMed ID: 23752073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases.
    Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S
    Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
    Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
    Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.
    Weidlich S; Bulau AM; Schwerd T; Althans J; Kappler R; Koletzko S; Mayr D; Bufler P
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):e18-26. PubMed ID: 24732025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased mucosal expression of GATA-3 and STAT-4 in pediatric ulcerative colitis.
    Ohtani K; Ohtsuka Y; Ikuse T; Baba Y; Yamakawa Y; Aoyagi Y; Fujii T; Kudo T; Nagata S; Shimizu T
    Pediatr Int; 2010 Aug; 52(4):584-9. PubMed ID: 20030749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of fish oil enriched enteral diet on inflammatory bowel disease tissues in organ culture: differential effects on ulcerative colitis and Crohn's disease.
    Meister D; Ghosh S
    World J Gastroenterol; 2005 Dec; 11(47):7466-72. PubMed ID: 16437718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crossover Subsets of CD4
    Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
    Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid receptors are down-regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel disease.
    Rogler G; Meinel A; Lingauer A; Michl J; Zietz B; Gross V; Lang B; Andus T; Schölmerich J; Palitzsch KD
    Eur J Clin Invest; 1999 Apr; 29(4):330-6. PubMed ID: 10231345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of interleukin 18 in intestinal mucosa of patients with inflammatory bowel disease and its implications].
    Zhang B; Lu Y; Hong T; Pei F; Li F; Wang X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 35(2):150-3. PubMed ID: 12920831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.
    Aloi M; Birimberg-Schwartz L; Buderus S; Hojsak I; Fell JM; Bronsky J; Veereman G; Koletzko S; Shaoul R; Miele E; Turner D; Russell RK
    Inflamm Bowel Dis; 2016 Jun; 22(6):1378-83. PubMed ID: 27135479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.
    Hölttä V; Klemetti P; Salo HM; Koivusalo A; Pakarinen M; Westerholm-Ormio M; Kolho KL; Vaarala O
    J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):287-92. PubMed ID: 23974060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.